Irida Kastrati

1.0k total citations
35 papers, 771 citations indexed

About

Irida Kastrati is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Irida Kastrati has authored 35 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Genetics and 13 papers in Oncology. Recurrent topics in Irida Kastrati's work include Estrogen and related hormone effects (16 papers), Cytokine Signaling Pathways and Interactions (8 papers) and NF-κB Signaling Pathways (6 papers). Irida Kastrati is often cited by papers focused on Estrogen and related hormone effects (16 papers), Cytokine Signaling Pathways and Interactions (8 papers) and NF-κB Signaling Pathways (6 papers). Irida Kastrati collaborates with scholars based in United States, Russia and Italy. Irida Kastrati's co-authors include Jonna Frasor, Gregory R. J. Thatcher, Lamiaa El-Shennawy, Judy L. Bolton, Zhihui Qin, Joshua D. Stender, Pavel A. Petukhov, Ping Yao, Marton I. Siklos and Emanuele Canestrari and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and PLoS ONE.

In The Last Decade

Irida Kastrati

33 papers receiving 766 citations

Peers

Countries citing papers authored by Irida Kastrati

Since Specialization

Citations

This map shows the geographic impact of Irida Kastrati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irida Kastrati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irida Kastrati more than expected).

Fields of papers citing papers by Irida Kastrati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irida Kastrati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irida Kastrati. The network helps show where Irida Kastrati may publish in the future.

Co-authorship network of co-authors of Irida Kastrati

This figure shows the co-authorship network connecting the top 25 collaborators of Irida Kastrati. A scholar is included among the top collaborators of Irida Kastrati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irida Kastrati. Irida Kastrati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unravelling the anti-cancer mechanisms elicited by non-covalent thioredoxin reductase inhibitors for triple negative breast cancer therapy 2025 ·Redox Biology ·(unknown), (unknown), (unknown), An Zhang, (unknown), (unknown), Samuel Yaw Aboagye, Maurizio Bocchetta, Wei Qiu, David L. Williams, Francesco Angelucci, Pavel A. Petukhov, Irida Kastrati	0
2	Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cells 2025 ·Breast Cancer Research ·(unknown), (unknown), Emma C. Fink, (unknown), (unknown), David A. Cooper, (unknown), (unknown), (unknown), Maarten C. Bosland, Donald R. Zak, (unknown), Marina N. Sharifi, Irida Kastrati, David D. L. Minh, Steven Kregel, Sean W. Fanning	0
3	The “Doorstop Pocket” In Thioredoxin Reductases─An Unexpected Druggable Regulator of the Catalytic Machinery 2024 ·Journal of Medicinal Chemistry ·Matteo Ardini, Samuel Yaw Aboagye, (unknown), Irida Kastrati, Rodolfo Ippoliti, Gregory R. J. Thatcher, Pavel A. Petukhov, David L. Williams, Francesco Angelucci	7
4	Pleiotropic anti-cancer activities of novel non-covalent thioredoxin reductase inhibitors against triple negative breast cancer 2024 ·Free Radical Biology and Medicine ·(unknown), Anthony F. Rullo, An Zhang, (unknown), (unknown), Samuel Yaw Aboagye, Francesco Angelucci, David L. Williams, Steven Kregel, Pavel A. Petukhov, Irida Kastrati	5
5	Dimethyl fumarate inhibits ZNF217 and can be beneficial in a subset of estrogen receptor positive breast cancers 2023 ·Breast Cancer Research and Treatment ·Tanu Sharma, Yuanjin Zhang, (unknown), Benjamin F. Cravatt, Irida Kastrati	1
6	Distinct Roles of SELENOF in Different Human Cancers 2023 ·Biomolecules ·(unknown), (unknown), (unknown), Alan M. Diamond, Irida Kastrati	7
7	Regulation of SELENOF translation by eIF4a3: Possible role in prostate cancer progression 2023 ·Molecular Carcinogenesis ·Soumen Bera, (unknown), (unknown), Waleed Ali, John Brockman, Maria Sverdlov, (unknown), (unknown), Andre Kajdacsy‐Balla, Klara Valyi‐Nagy, (unknown), Irida Kastrati, Li Liu, Alan M. Diamond	2
8	Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors 2022 ·Breast Cancer Research ·Svetlana E. Semina, (unknown), (unknown), (unknown), Irida Kastrati, Carol A. Sartorius, Jonna Frasor	3
9	The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers 2020 ·Molecular Cancer Research ·Irida Kastrati, Stacey E. P. Joosten, Svetlana E. Semina, (unknown), Svitlana D. Brovkovych, Joshua D. Stender, Hugo M. Horlings, Marleen Kok, Elaine T. Alarid, Geoffrey L. Greene, Sabine C. Linn, Wilbert Zwart, Jonna Frasor	38
10	Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer 2019 ·Molecular and Cellular Endocrinology ·Irida Kastrati, Svetlana E. Semina, Benjamin Gordon, (unknown)	16
11	Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer 2017 ·Cancer Research ·Lamiaa El-Shennawy, Oleksii Dubrovskyi, Irida Kastrati, Jeanne M. Danes, Yiqun Zhang, Herbert E. Whiteley, Chad J. Creighton, Jonna Frasor	32
12	Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine‐based Histone Deacetylase Inhibitors 2017 ·ChemMedChem ·Hazem Abdelkarim, (unknown), Antonett Madriaga, Aditya S. Vaidya, Irida Kastrati, (unknown), (unknown), Taha Y. Taha, Gregory R. J. Thatcher, Jonna Frasor, Pavel A. Petukhov	9
13	A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy 2017 ·Hormones and Cancer ·Irida Kastrati, Marton I. Siklos, Svitlana D. Brovkovych, Gregory R. J. Thatcher, Jonna Frasor	7
14	Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells 2017 ·Journal of Visualized Experiments ·Irida Kastrati, (unknown), (unknown), Gregory R. J. Thatcher, Jonna Frasor	6
15	A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties 2015 ·BMC Cancer ·Irida Kastrati, Vladislav A. Litosh, Shuang Zhao, Manuel Álvarez, Gregory R. J. Thatcher, Jonna Frasor	19
16	PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres 2014 ·Oncogene ·Irida Kastrati, Emanuele Canestrari, Jonna Frasor	49
17	NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms 2014 ·Molecular and Cellular Endocrinology ·Jonna Frasor, Lamiaa El-Shennawy, Joshua D. Stender, Irida Kastrati	50
18	Raloxifene and Desmethylarzoxifene Block Estrogen-Induced Malignant Transformation of Human Breast Epithelial Cells 2011 ·PLoS ONE ·Irida Kastrati, (unknown), (unknown), (unknown), Jae Woo Choi, Yueting Wang, Judy L. Bolton, Gregory R. J. Thatcher	10
19	Structural Modulation of Oxidative Metabolism in Design of Improved Benzothiophene Selective Estrogen Receptor Modulators 2008 ·Drug Metabolism and Disposition ·Zhihui Qin, Irida Kastrati, (unknown), Daniel D. Lantvit, Cassia Overk, Yongsoo Choi, Richard B. van Breemen, Judy L. Bolton, Gregory R. J. Thatcher	14
20	Structure–Activity Relationships for a Family of Benzothiophene Selective Estrogen Receptor Modulators Including Raloxifene and Arzoxifene 2007 ·ChemMedChem ·Cassia Overk, (unknown), (unknown), Irida Kastrati, Daniel D. Lantvit, Zhihui Qin, Jonna Frasor, Judy L. Bolton, Gregory R. J. Thatcher	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact